ENEmiliano Marco Navarra

Emiliano Marco Navarra

*This is an algorithmically generated author record based on publicly available information.

Emiliano Marco Navarra has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • European Association of Cardiothoracic Surgeons future view on robotic cardiac surgery in Europe

    by Wouter Oosterlinck, Monica Gianoli, Meindert Palmen, Thierry Folliguet, Johannes Bonatti, Alfonso Agnino, Sandeep Singh, Ulrich Franke, Paul Modi, Daniel Pereda, et al.

    The implementation of robotic surgical systems has reduced the invasive nature of certain cardiac surgical procedures over the recent decades. In the early days, coronary artery bypass grafting (CABG) and mitral valve repair (MVR) were mostly performed through a conventional sternotomy approach. Over time, however, minimally invasive techniques, including endoscopic methods, have become routine, particularly for MVR and MIDCAB procedures. The introduction of robotic surgical systems in the 1990s further advanced these techniques, offering valuable opportunities for continued innovation. This evolution is also closely linked with Enhanced Recovery After Cardiac Surgery (ERACS) and other related concepts that have become integral to modern cardiac surgery. However, technical, logistic and cost-related issues, related to the robotic platform, have hampered and slowed down the widespread adoption of the robotic CABG procedure [ 1]. Innovations and especially technical ones do not emerge gradually and constantly but come in waves. In the beginning, innovations are almost always cumbersome, unreliable, expensive and without any convenient infrastructure, e.g. printing press, electricity, railroads, cars, computers. The dissemination of innovations is therefore costly, slow, risky and entails drastic changes in behaviour [ 2]. After many decades, the introduction of an innovation may look perfectly smooth and easy. However, every innovation must fight against existing interests, established knowledge and those who staunchly defend both. Fear and mistrust of everything new and different are endemic.


  • Hybrid Coronary Revascularization in Multivessel Disease: The Ideal Strategy for Challenging Scenarios

    by Antonella Tommasino, Emiliano Marco Navarra, Federico Dell'AQuila, Camilla Ciani, Vincenzo Fiorentini, Simone Amicizia, Andrea Berni, Emanuele Barbato, Giovanni Melina

    The treatment of coronary artery disease (CAD) has considerably evolved over the last three decades thanks to innovations in percutaneous and surgical revascularization techniques. The demographic shift towards an aging population with complex coronary anatomy and multiple comorbidities necessitates a personalized approach. A primary challenge for Heart Teams is to integrate new strategies into their decision-making process. Hybrid coronary revascularization (HCR) combines the long-term benefits of coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) to treat complex coronary artery disease. Selection of the ideal candidate for HCR requires careful evaluation of anatomic challenges and risk profiles. Although recent evidence demonstrates the safety and efficacy of HCR and makes it a viable alternative to conventional methods, further large-scale randomized controlled trials (RCTs) are needed to establish its role in routine practice. In this manuscript, we have provided an overview of the major advances in both percutaneous and surgical techniques. In addition, we have addressed the innovative implications of robotic-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB) and described the surgical procedure and postoperative care in detail. Finally, we have outlined the key principles that guide our clinical practice in selecting the appropriate approach for hybrid coronary revascularization.